The pharmacokinetic effect of the specific ETA receptor antagonist zibotentan (ZD4054) on CYP3A4 activity using midazolam as a probe in healthy male volunteers

Authors
Category Primary study
JournalEuropean Journal of Cancer, Supplement
Year 2009
This article has no abstract
Epistemonikos ID: 3e4f53c22ddbbf8a732e6cc385e109a7a0542da5
First added on: Mar 01, 2025